Oral Presentations

2019                          Germany, University Freiburg, Pharmaceutical Sciences (GMP)

2019                          Germany, University Offenburg, Univ. of Applied Sciences (REG. Affairs, drugs and devices, EMA)

2019                          Germany, University Freiburg, Pharmaceutical Sciences (GMP, Quality Metrics, Control Strategy)

2018                          Germany, University Offenburg, Univ. of Applied Sciences (REG. Affairs, drugs and devices, EMA)

2018                          Germany, University Freiburg, Pharmaceutical Sciences (GMP, Stability Testing, Biologics)

2018                          Germany, University Freiburg, Pharmaceutical Sciences (GMP)

2017                          Germany, Freiburg (University Freiburg, SGBM (Introduction to GxP regulatory world)

2017                          Germany, Freiburg (Company), Ancillary Materials Regulations

2016:                         Germany, Freiburg (University Freiburg, SGBM (Introduction to GxP regulatory world)

2015:                         France, Strasbourg, (EUCRAF; EU GLP, EU-GMP and GDP)

2015:                         Switzerland, Interlaken (Implants: Medical Devices, Regulatory US versus EU)

2014:                         Germany, Düsseldorf (MEDICA  - KOREAN NIGHT: “Marketing Medical Devices:
                                  Regulatory Hurdles”, Invited by KHIDI & KOTRA)

2014:                         France, Strasbourg, (EUCRAF; EU GLP, EU-GMP and GDP)

2013:                         France, Strasbourg, (EUCRAF; EU GLP)

2013:                         France, Strasbourg, (EUCRAF; EU GLP, EU-GMP and GDP)

2013:                         China, Hanghzou, Vaccine congress (Cell bank safety, CMC, Quality, Regulatory Affairs)

2012:                         Germany, Frankfurt (Medical Devices, Biomarker)

2012:                         China, Shanghai, Vaccine congress (Cell bank safety, CMC, Quality, Regulator Affairs)

2012:                         France, Strasbourg, (EUCRAF; EU GLP and EU-GMP)

2012:                         Denmark, Copenhagen, EU DIA Annual Meeting (ATMP, Quality, CMC)

2012:                         Italy, Siena (Vaccines, authorization world wide)

2012:                         Switzerland, Basel, (Combination drug/device products, regulatory)

2011:                         France, Strasbourg, (EUCRAF; EU-GMP, EU GLP)

2011:                         USA, Chicago, DIA Annual Meeting, (Quality, Unwanted Immunogenicity, reverse vaccinology, in silico tools)

2011:                         Germany, Freiburg, Cellgenix, (ATMP Regulations)

2010:                         USA, Philadelphia (Quality, Unwanted Immunogenicity)

2010:                         USA, Washington DC, DIA Annual Meeting, (Quality, Unwanted Immunogenicity)

2009:                         USA, San Diego DIA Annual Meeting, (Quality, Unwanted Immunogenicity, Medical  Device Quality Management System)

2008:                         Germany, Hamburg, (Quality, Unwanted Immunogenicity)

2008:                         USA, Boston, DIA Annual Meeting (Quality, Cell banks, ATMP)

2008:                         United Kingdom, Cambridge, In-vitro Diagnostics Summer School (GMP for Medical   Devices)

2007:                         Czech Republic, Prague (Quality, Unwanted Immunogenicity), workshop

2007:                         Austria, Salzburg, (Epidemiology, Emerging Pathogens)

2007:                         Austria, Vienna (Medical Devices,Virology, EBV diagnostics)

2006:                         Israel, Tel Aviv: (Medical Devices, Virology, EBV diagnostics)

2005:                         South Africa: Cape Town, Johannesburg, Pretoria, December, (Medical Devices, Virology, diagnostics)

2005:                         South Africa: Plenary Lecturer: Cape Town (EBV diagnostics); Johannesburg,  Pretoria, Durban, (Medical Devices, Virology, diagnostics)

2004:                         South Africa: Cape Town, Johannesburg, Pretoria, (Medical Devices, Virology and    Bacteriology

2004:                         Finnland, Helsinki: (Medical Devices, Virology (EBV), EHEC diagnostics)

2004:                         Sweden: Stockholm, Tromsoe, (Medical Devices, Virology, diagnostics)

2004:                         USA: San Diego (Medical Devices, Virology, diagnostics)

2003:                         Norway: Oslo, Trondheim, Bergen (Medical Devices, Virology, Bacteriology)

2003:                         Italy, Padua, Florence (Medical Devices, Virology, diagnostics)

2002:                         Germany: Mannheim (Medical Devices, Virology diagnostics)

2002:                         South Africa: Cape Town, Johannesburg, Pretoria, Durban (Medical Virology)

2001:                         USA: San Diego, (Medical Devices, Virology (EBV), diagnostics)

2000:                         USA: Cincinnati, (Medical Devices, Bacteriology (EHEC) diagnostics)

1999:                         USA: Chicago (Medical Devices, Bacteriology (EHEC) diagnostics),

1998:                         USA: Boston & San Diego (Total Quality Management, Medical Devices)

1997:                         Switzerland, Zurich (Medical Devices, Bacteriology (EHEC) diagnostics)

1997:                         USA: San Diego (Medical Devices, Virology (EBV), diagnostics)

1997:                         USA: Boston (Virology, diagnostics)

1996:                         USA: San Diego: (Medical Devices, Virology (EBV),

1996:                         USA: Boston, Cincinnati, (Medical Devices, Bacteriology (EHEC, diagnostics)

1996:                         Italy, Milano: (Medical Devices, Bacteriology (EHEC), diagnostics)

1996:                         Germany: Heidelberg (Oncology)

1995:                         Switzerland, Neuchatel (Medical Devices, Bacteriology (EHEC), diagnostics

1995:                         Germany, Saarbrücken (Virology, vaccines)

1995:                         German, Heidelberg (Oncology, p53, apoptosis),

1994:                         Germany, Jena (Virology, vaccines)

1994:                         Germany, Heidelberg (Oncology,p53, apoptosis),

1993:                         Germany, Frankfurt (Virology, vaccines)

1993:                         Germany, Heidelberg (Oncology, p53, apoptosis),

1992:                         Germany, Würzburg (Tumor virology, peptide vaccines)

1992:                         Germany, Heidelberg (Oncology, p53, apoptosis),

1991:                         Germany: Heidelberg (Oncology, p53, apoptosis)

1991:                         United Kingdom, Cambridge (Tumor virology, peptide vaccines)

1990:                         Germany, Heidelberg (Tumor virology, peptide vaccines)

1989:                         Germany, Heidelberg (Tumor virology, peptide vaccines)

 

This site was designed with the
.com
website builder. Create your website today.
Start Now